Dr. Robert Jones is a professor of Clinical Cancer Research at the University of Glasgow School of Cancer Sciences, in Scotland.
February 15, 2025
Article
Following treatment with Bavencio, patients with urothelial cancer lived for 17 months and their cancer remained stable for nine months.
Colorectal Cancer on Rise in Young Adults, Answers May Be Years Away
Personalized Cancer Vaccine Generates Responses Across Cancer Types
Understanding the Use of Bispecific Antibodies in Multiple Myeloma
How Personalized Medicine May Impact Gastrointestinal Cancer Treatment